The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemotherapy in the oldest old: The feasibility of cytotoxic therapy in the 80+ population.
Shelly Sud
No relevant relationships to disclose
Pamela Lai
No relevant relationships to disclose
Katelyn Balchin
No relevant relationships to disclose
Mark Clemons
No relevant relationships to disclose
Paul Wheatley-Price
No relevant relationships to disclose